BMC ophthalmology · 2026
Outcomes of primary orbital implantation in evisceration/enucleation in patients with endophthalmitis in a tertiary hospital.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Alrashed Saleh, Alnefaim Maram, Althaqib Rawan N, Alsulaiman Hamad M
Аннотация
PURPOSE: To evaluate the safety and outcomes of primary orbital implantation during evisceration/enucleation for endophthalmitis, specifically analyzing the risk of implant exposure/extrusion.
METHODS: Retrospective review of 98 endophthalmitis patients (90 eviscerations, 8 enucleations) who received a primary orbital implant (mostly PMMA) over 10 years. Follow-up averaged 27.5 months.
RESULTS: Postoperative implant exposure/extrusion occurred in 10 patients (10.2%). This rate is comparable to established literature. The mean time to exposure was 140 days. Neither preoperative orbital cellulitis nor culture positivity (e.g., Pseudomonas) was statistically associated with a higher risk of exposure. Re-operations for exposure did not show evidence of active, ongoing infection.
CONCLUSION: Primary orbital implantation in endophthalmitis patients is safe, carrying an exposure/extrusion risk (10.2%) comparable to reported rates. The procedure should be favored over a two-staged approach unless significant inflammation is noted intraoperatively. PRéCIS: The purpose of this paper is to study outcomes of primary orbital implantation in Endophthalmitis patient, and to review the exposure rate, and to also analyze possible risk factors for the exposure/extrusion.
METHODS: Retrospective review of 98 endophthalmitis patients (90 eviscerations, 8 enucleations) who received a primary orbital implant (mostly PMMA) over 10 years. Follow-up averaged 27.5 months.
RESULTS: Postoperative implant exposure/extrusion occurred in 10 patients (10.2%). This rate is comparable to established literature. The mean time to exposure was 140 days. Neither preoperative orbital cellulitis nor culture positivity (e.g., Pseudomonas) was statistically associated with a higher risk of exposure. Re-operations for exposure did not show evidence of active, ongoing infection.
CONCLUSION: Primary orbital implantation in endophthalmitis patients is safe, carrying an exposure/extrusion risk (10.2%) comparable to reported rates. The procedure should be favored over a two-staged approach unless significant inflammation is noted intraoperatively. PRéCIS: The purpose of this paper is to study outcomes of primary orbital implantation in Endophthalmitis patient, and to review the exposure rate, and to also analyze possible risk factors for the exposure/extrusion.